Tuberculosis in the Czech Republic in 1997
Authors:
L. Trnka; F. Krejbich
Authors‘ workplace:
Jednotka dohledu nad tuberkulózou, FN Bulovka, PrahaKlinika pneumologie a hrudní chirurgie 3. LF UK, Praha
Published in:
Čas. Lék. čes. 1999; : 460-464
Category:
Overview
In the Czech Republic in 1997 1834 new cases of TB and relapses were notified, i.e. 17.8 patients per 100 000population. This number comprised 1557 cases of TB of respiratory tract (15.1 patients per 100 000 population). Bybacteriological examination 952 new cases of respiratory TB were confirmed (9.2 per 100 000 population) wherebyin 524 patients the sputum was direct smear positive. There were 277 (2.7/100 000) extrapulmonary forms. TB waswere in 1997 the cause of death of 62 patients (0.6/100 000). These numbers did not differ significantly from datarecorded in 1990 - 1996 and we may conclude from them that the stagnating character of TB persists. Newly detectedcases of pulmonary TB (affection of the pulmonary parenchyma only) were recorded in 1328 patients.The notifications made it possible to create a set of direct and indirect epidemiological indicators (age distribution,TB mortality) which made it possible to provide evidence that in this country the validity-notification did not changesubstantially in recent years.
Key words:
tuberculosis, screening of tuberculossi, tuberculosis register, epidemiological survey.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Chlamydiae - Ever New Surprises
- Standard Epicutaneous Tests in Ambulatory Patients of the Dermatovenerological Clinic
- History of the Eradication of Bovine Tuberculosis in the Czech Republic
- Application of Citation Indexes and Impact Factor